Brian V. Slater, Partner, Kramer Levin Naftalis & Frankel LLP to Speak at TKGs Event
Summary
In a two-hour live Webcast, a panel of thought leaders and practitioners assembled by The Knowledge Group will discuss the significant and latest issues surrounding the BPCIA.The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format.To contact or register for an event, please visit: http://theknowledgegroup.org/ New York, NY, January 21, 2017 --( PR.com )-- The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Brian V. Slater, Partner, Kramer Levin Naftalis & Frankel LLP will speak at the Knowledge Group’s webcast entitled: “Resolving Patent Dispute Under BPCIA: Latest Developments and Strategies in 2017 Live Webcast.” This event is scheduled for February 14, 2017 from 3:00pm – 5:00pm (ET).For further details, please visit: https://theknowledgegroup.org/event-homepage/?event_id=2111About Brian V. SlaterBrian V. Slater, is Chair of the Life Sciences practice at Kramer Levin Naftalis & Frankel LLP.Primarily, the act caters for products which are “biosimilar” to or “interchangeable” with FDA-licensed biological products.One of the most significant cases on BPCIA was the recently culminated Amgen-Sandoz Fight, which created a buzz on the industry and questioned how mandatory the “Patent Dance” is.In a two-hour live Webcast, a panel of thought leaders and practitioners assembled by The Knowledge Group will discuss the significant and latest issues surrounding the BPCIA.The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format.